引用本文
  •    [点击复制]
  •    [点击复制]
PDF HTML全文阅读
本文已被:浏览 437次   下载 378 本文二维码信息
码上扫一扫!
线粒体氧化磷酸化抑制剂对紫杉醇耐药的三阴性乳腺癌细胞衰老的影响
牛利刚,周瑜辉,周灿,闫宇,何建军
西安交通大学第一附属医院乳腺外科陕西西安 710061
摘要:
目的:探究线粒体氧化磷酸化(OXPHOS)抑制剂对紫杉醇耐药的三阴性乳腺癌细胞衰老的影响。方法:构建对盐酸多柔比星(DOX)耐药的三阴性乳腺癌细胞株(MDA-MB-231/DOX)。通过CCK-8检测不同浓度(0.05、0.1和0.2 μmol/L)OXPHOS抑制剂和处理不同时间(24 h、48 h和72 h)对MDA-MB-231/DOX细胞活力的影响。分别给予0.1 μmol/L OXPHOS抑制剂IACS-010759或者等量的二甲基亚砜(DMSO)处理48 h,分别记作MDA-MB-231/DOX+OXPHOS抑制剂组和MDA-MB-231/DOX组。通过线粒体压力测定比较两组细胞的线粒体呼吸能力,通过流式细胞术比较两组细胞周期的变化,通过蛋白质印迹比较两组细胞p53、p21、p16、过氧化物酶体增殖物激活受体γ辅助活化因子1α(PGC-1α)及线粒体动力相关蛋白1(Drp1)蛋白表达的水平。结果:与MDA-MB-231/DOX细胞相比,MDA-MB-231/DOX+OXPHOS抑制剂组细胞的最大呼吸能力、备用呼吸能力及ATP合成能力均显著减弱,质子漏升高(P <0.001)。细胞周期检测结果发现,与MDA-MB-231/DOX细胞相比,MDA-MB-231/DOX+OXPHOS抑制剂组G0/G1期细胞比例显著升高,S期和G2/M期细胞比例显著降低(P <0.05),并且伴随着p53、p21和p16蛋白表达上调(P <0.001)。与MDA-MB-231/DOX细胞相比,MDA-MB-231/DOX+OXPHOS抑制剂组细胞的PGC1-α和Drp1表达显著降低(P <0.001)。结论:OXPHOS抑制剂能够降低MDA-MB-231/DOX细胞对紫杉醇的耐药性,诱导细胞衰老,可能与PGC-1α/Drp1信号通路抑制有关。
关键词:  三阴乳腺癌  耐药细胞  紫杉醇  线粒体氧化磷酸化  细胞衰老  PGC1-α/Drp1信号通路
DOI:10.3969/j.issn.1007-6948.2025.04.020
投稿时间:2024-12-10
基金项目:陕西省重点研发计划项目(2021SF-203)
Effects of inhibitors of mitochondrial oxidative phosphorylation on paclitaxel resistance and cellular senescence in drug-resistant triple-negative breast cancer cells
NIU Li-gang,ZHOU Yu-hui,ZHOU Can
Department of Breast Surgery, The First Affiliated Hospital of Xi′an Jiaotong University, Xi'an, Shaanxi 710061,China
Abstract:
Objective To investigate the effect of mitochondrial oxidative phosphorylation inhibitors on senescence of paclitaxel-resistant triple-negative breast cancer cells. Methods The triple-negative breast cancer cells MDA-MB-231 resistant to doxorubicin hydrochloride (DOX) MDA-MB-231/DOX were constructed. Thereafter, different concentrations (0.05, 0.1 and 0.2 μmol/L OXPHOS inhibitor) and different treatment time (24 h, 48 h and 72 h) on the viability of MDA-MB-231/DOX cells were detected by CCK-8. Mitochondrial respiration capacity of the two groups was compared by mitochondrial pressure measurement, and cell cycle changes were compared by Flow Cytometry. The expression of p53, p21, p16, peroxisome proliferator-activated receptor γ-coactivation factor 1α (PGC-1α) and mitochondrial dynamic-associated protein-1 (Drp1) in the two groups were compared by western blot. Results Compared with MDA-MB-231/DOX cells, the maximum respiratory capacity, spare respiratory capacity and ATP synthesis capacity of MDA-MB-231/DOX+OXPHOS inhibitor cells were significantly decreased (P <0.01), and proton leakage was increased (P <0.001). Compared with MDA-MB-231/DOX cells, the cell cycle detection results showed that the proportion of G0/G1 phase cells in MDA-MB-231/DOX+OXPHOS inhibitor group was significantly increased, and the proportion of S phase cells and G2/M phase cells was significantly decreased (P <0.05). It was accompanied by up-regulation of p53, p21 and p16 proteins (P <0.001). Furthermore, compared with MDA-MB-231/DOX cells, PGC1-α and Drp1 expressions in MDA-MB-231/DOX+OXPHOS inhibitor groups were significantly decreased (P <0.001). Conclusion OXPHOS inhibitors can reduce paclitaxel resistance in MDA-MB-231/DOX cells and induce cell senescence, which may be related to the inhibition of PGC-1α/Drp1 signaling pathway.
Key words:  Triple negative breast cancer  drug resistant cells  paclitaxel  mitochondrial oxidative phosphorylation  cell senescence  PGC1-α/Drp1 signaling pathway

用微信扫一扫

用微信扫一扫